Freenome, Inc. (FRNM) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Retained Earnings (Accumulated Deficit)USD $-6.30M; Stockholders' Equity Attributable to ParentUSD $-6.30M; Adjustments to Additional Paid in Capital, Stock Issued, Issuance CostsUSD (m).
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Retained Earnings (Accumulated Deficit)USD $-5.66M; Stockholders' Equity Attributable to ParentUSD $-5.66M; Adjustments to Additional Paid in Capital, Stock Issued, Issuance CostsUSD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Retained Earnings (Accumulated Deficit)USD $-4.80M; Stockholders' Equity Attributable to ParentUSD $-4.80M; Adjustments to Additional Paid in Capital, Stock Issued, Issuance CostsUSD (m).
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Retained Earnings (Accumulated Deficit)USD $-3.12M; Stockholders' Equity Attributable to ParentUSD $-3.12M; Adjustments to Additional Paid in Capital, Stock Issued, Issuance CostsUSD (m).
Freenome, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|
| 2026-06-30 | $0.00 | $-6.30M | $-6.30M | (m) |
| 2026-03-31 | $0.00 | $-5.66M | $-5.66M | (m) |
| 2025-12-31 | $0.00 | $-4.80M | $-4.80M | (m) |
| 2025-09-30 | $0.00 | $-3.12M | $-3.12M | (m) |
| 2025-06-30 | $0.00 | $-2.27M | $-2.27M | (m) |
| 2025-03-31 | $0.00 | $-2.37M | $-2.37M | (m) |
| 2024-12-31 | $0.00 | $-2.12M | $-2.12M | 9 month · $15.97K |
| 2024-09-30 | $0.00 | $-1.94M | $-1.94M | (m) |
| 2024-06-30 | $0.00 | $-1.74M | $-1.74M | (m) |
| 2024-03-31 | (m) | (m) | $9.60K | (m) |
| 2024-03-21 | (m) | (m) | $0.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |